Fixed dose rivaroxaban can be used in extremes of bodyweight: A population pharmacokinetic analysis by Speed, Victoria, Green, Bruce, Roberts, Lara N., Woolcombe, Sarah, Bartoli‐Abdou, John, Barsam, Sarah, Byrne, Rosalind, Gee, Emma, Czuprynska, Julia, Brown, Alison, Duffy, Sinead, Vadher, Bipin, Patel, Rachna, Scott, Valerie, Gazes, Anna, Patel, Raj K., Arya, Roopen, Patel, Jignesh P.

Get full text

Exploration of adherence and patient experiences with DOACs one year after switching from vitamin-K antagonists- insights from the switching study by Bartoli- Abdou, John K., Patel, Jignesh P., Crawshaw, Jacob, Vadher, Bipin, Brown, Alison, Roberts, Lara N., Patel, Raj K., Arya, Roopen, Auyeung, Vivian

Get full text

Associations between illness beliefs, medication beliefs, anticoagulation‐related quality of life, and INR control: Insights from the Switching Study by Bartoli‐Abdou, John K., Patel, Jignesh P., Xie, Rosa, Dzahini, Olubanke, Vadher, Bipin, Brown, Alison, Roberts, Lara N., Patel, Raj K., Arya, Roopen, Auyeung, Vivian

Get full text

Long-term adherence to direct acting oral anticoagulants and the influence of health beliefs after switching from vitamin-K antagonists: Findings from the Switching Study by Bartoli-Abdou, John K., Patel, Jignesh P., Vadher, Bipin, Brown, Alison, Roberts, Lara N., Patel, Raj K., Arya, Roopen, Auyeung, Vivian

Get full text

Clinical outcomes of patients receiving long-term fondaparinux for thrombotic antiphospholipid syndrome by Bor, Buse, Doyle, Andrew J, Bartoli-Abdou, John K, Hackett, Anthony, Collings, Victoria, Omrani, Fatima, Foskett, Carl, Wareing, Anne, Young, Johanna, Breen, Karen A, Hunt, Beverley J

Get full text

The transition from hospital to home following acute coronary syndrome: an exploratory qualitative study of patient perceptions and early experiences in two countries by Crawshaw, Jacob, Bartoli-Abdou, John K, Weinman, John, McRobbie, Duncan, Stebbins, Marilyn, Brock, Tina, Auyeung, Vivian

Get full text